PD-1-specific “Blocking” antibodies that deplete PD-1+ T cells present an inconvenient variable in preclinical immunotherapy experiments

Fanny Polesso, Michael W. Munks, Katherine H. Rott, Savannah Smart, Ann Hill, Amy E. Moran

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'PD-1-specific “Blocking” antibodies that deplete PD-1<sup>+</sup> T cells present an inconvenient variable in preclinical immunotherapy experiments'. Together they form a unique fingerprint.

Medicine & Life Sciences